Pharma Focus Asia

Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI

Wednesday, February 08, 2023

Syneos Health® announced a strategic partnership with Haystack Health to improve the identification and enrolment of patients for clinical trials.

The combination of Syneos Health with Haystack Health will more effectively and efficiently identify and match clinical trial opportunities for patients. For sponsors and sites, this partnership will deliver valuable research tools and workflow efficiencies resulting in improved timelines and increased patient recruitment. Initially, the new data solutions will only be available for Syneos Health sites in the US, with a focus on oncology and immunology. Later this year, the partnership plans to expand to include additional therapeutic areas and sites across the globe.

The challenges of enrolling patients in clinical trials are well documented. Protocol complexity and specificity in precision medicine are making patient recruitment even more difficult. Haystack Health offers an advanced solution leveraging AI to match patients to trials while preserving privacy.

The companies’ combined capabilities help improve recruitment strategy to focus on patients who are less likely to fail trial screeners, reducing the burden on patients, trials and sites.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024